Mumbai: Vaccinations for the Covid-19 are on in the country. Indians who have been fully vaccinated by both doses of Bharat Biotech’s Covaxin might be in trouble in case they want to travel abroad.
According to a report in LiveHindustan, they not be allowed to travel internationally as the vaccine produced by Bharat Biotech has not been listed in World Health Organization’s (WHO) Emergency Use Listing (EUL) yet.
Indians are depending heavily upon Covishield and Covaxin vaccines. Covishield, which is manufactured by the Serum Institute of India in association with AstraZeneca and the University of Oxford, is not completely indigenous.
While Covaxin is a wholly indigenous vaccine developed by Hyderabad-based pharma company Bharat Biotech.
“As several nations in Europe are reopening in a bid to boost their travel and tourism industries, they are likely to make regulations for entry of travellers based on recommendations of their respective health departments or are likely to allow people vaccinated with the shots manufactured by companies which are on WHO’s EUL list,” the report said.
WHO listed the Pfizer/BioNTech vaccine for emergency use on December 31, 2020; and two AstraZeneca/Oxford COVID-19 vaccines on February 15, produced by AstraZeneca-SKBio (Republic of Korea) and the Serum Institute of India; and the COVID-19 vaccine Ad26.COV2.S developed by Janssen (Johnson & Johnson) on March 12. The UN body has also granted approval to Moderna’s Covid-19 vaccine and included China’s Sinopharm vaccine in its EUL.
But in the case of Covaxin, the WHO is yet to take a call on its inclusion in EUL.